View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part I - Diagnosis and Staging on demand.
Videos
In an interview, Dr. Nina Shah of UCSF Helen Diller Family Comprehensive Cancer Center discusses how she changed her perspective on finding a cure for myeloma and what her goals are when it comes to treating her patients.
CURE spoke with Dr. Marty T. Sellers and Dr. Laura M. Kulik, on behalf of the Blue Faery, about liver cancer and disease – its treatments, causes and areas outside of therapy.
In an interview, Dr. Andrew Yee of Massachusetts General Hospital discusses how a multiple myeloma diagnosis affects a patient’s life and how hopeful he is about helping them lead normal lives.
In an interview, Dr. Nina Shah of UCSF Helen Diller Family Comprehensive Cancer Center explains what a myeloma millennial, or ‘myelennial,’ is, and how recent advances in multiple myeloma treatments inspired the term.
The term “survivor” is often used to describe people who have successfully completed their cancer treatments, but Sonia Su feels like it doesn’t quite capture the complexity of what it means to be in remission.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses the learning curve of taking an oral medication, tucatinib, in combination with chemotherapy, and Sara A. Hurvitz, M.D., reviews methods for medication adherence.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, discusses how her quality of life has been since she began taking tucatinib with chemotherapy.
Sara A. Hurvitz, M.D., reviews the advances in HER2+ metastatic breast cancer that have been made over the past decade.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her goals of treatment after progression of disease.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares the hope she had after progression because of the ongoing research for HER2+ breast cancer, and Sara A. Hurvitz, M.D., reviews the drug regimens available in this realm.
Although “social distancing” has become a common term used to describe the safe distance people keep from others to avoid contracting COVID-19, stage 1 ovarian cancer survivor and teacher Brenda Kowalski reminds patients who may be starting out on their cancer journey that it’s important to not “socially distance” yourself from friends when you need support.
Sara A. Hurvitz, M.D., reviews the history of HER2+ breast cancer and the progressive research that has been done in this disease.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, describes her experience learning about the surplus of treatment options and how she overcame her initial apprehension.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares her initial impression of when she was diagnosed.
Sara A. Hurvitz, M.D., describes the subtypes, staging and grading of breast cancer.
Improving Outcomes for Patients With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
A Caregiver’s Perspective on Treatment Success
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Feeling Supported During the Diagnosis and Treatment of Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
View the full CURE Educated Patient Multiple Myeloma Summit on demand.
George Valentine needs something from his elected representatives in Congress: securing predictable annual out-of-pocket costs under Medicare Part D’s prescription drug plan.
Nearly one year ago to the day, 24-year-old Nina Luker was completely blindsided by a diagnosis of non-Hodgkin lymphoma. But after powering through treatments in the thick of the COVID-19 pandemic, Luker is now cancer-free and offering advice to those who may be looking for ways to help their loved ones through difficult times of their own.
Effect of Brain Metastasis Treatment on Quality of Life
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Individual Assessment of Treatment Success With Brain Metastases
ByPriscilla Brastianos, MD, Massachusetts General Hospital of Harvard Medical School,Manmeet Ahluwalia, MD, Cleveland Clinic,Raymond Sawaya, MD, MD Anderson Cancer Center,Vinai Gondi, MD, Northwestern Medicine Cancer Center,Ralph DeVitto, American Brain Tumor Association (ABTA),Ivy Elkins, Patient,Katie Doble, Patient,Nick Doble, Caregiver
Advertisement
Advertisement
Trending on CURE
1
Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital
2
An Educational Overview of Newly Diagnosed Stage 1 Myelofibrosis
3
What Ikebana Teaches a Patient on Their Cancer Journey
4
How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma
5
